This book presents recent advancements, challenges, and clinical
implications of molecular biomarkers in various cancers. This book
highlights the clinical applications of biomarkers are extensive
for cancer risk assessment, screening and early detection of
cancer, accurate diagnosis, patient prognosis, prediction of
response to therapy, and cancer surveillance and monitoring
response. It also explores the progress of predictive biomarkers as
an adjunctive tool to tumor immunotherapy in effectively
identifying the efficacy of immune checkpoint inhibitors and
discusses their future directions in achieving precision
immuno-oncology. Further, the book examines the combination of
next-generation sequencing and advanced computational data analysis
approaches in the understanding of the genomic underpinnings of
cancer development and progression. Towards the end, the chapter
discusses the role of some commonly investigated phytochemicals and
their epigenetic targets that are of particular interest in cancer
prevention and cancer therapy. It is a must for researchers as well
as advanced students and physicians in the field of cancer and
clinical oncologists.
General
| Imprint: |
Springer Verlag, Singapore
|
| Country of origin: |
Singapore |
| Release date: |
September 2023 |
| First published: |
2023 |
| Editors: |
Ranbir Chander Sobti
• Haruhiko Sugimura
• Aastha Sobti
|
| Dimensions: |
235 x 155mm (L x W) |
| Pages: |
738 |
| Edition: |
1st ed. 2023 |
| ISBN-13: |
978-981-9937-45-5 |
| Categories: |
Books
|
| LSN: |
981-9937-45-0 |
| Barcode: |
9789819937455 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
Welcome to Loot.co.za!
Sign in / Register |Wishlists & Gift Vouchers |Help | Advanced search
